Blog

New Approach for the CAR-T Cell Therapy Treatment of Cancer – BioPharm International

New Approach for the CART Cell Therapy Treatment of Cancer
BioPharm International
Research from Osaka University has revealed a new target for the treatment of cancer using monoclonal antibodies (mAbs). The new strategy was discovered by reevaluating the antigens typically targeted by mAb-based treatments using chimeric antigen

2018-01-12 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.